/
partner with:

antibodies

number of breaks: 8

showing 1-5 of 8 breaks

Monoclonal antibodies that are effective against all COVID-19 -related viruses

In late 2019, a novel coronavirus approximately 80% similar to the virus that caused the Severe Acute Respiratory Syndrome (SARS) in 2003 was first reported in China. This virus designated as SARS-2 (the COVID-19 virus) later swept through the globe, causing millions of infections and... click to read more

  • Wan Ni Chia | Senior Research Fellow at Duke-NUS Medical School
Views 2188
Reading time 3.5 min
published on Jan 31, 2024
How the immune response to a common virus may target the brain in multiple sclerosis

Over 2.8 million individuals are living with multiple sclerosis (MS) which occurs when the brain and spinal cord become damaged due to inflammation. Persons with MS (pwMS) experience various symptoms such as vision disturbance, cognitive dysfunction and problems with balance and mobility. Around 85% of... click to read more

  • Olivia Thomas | Postdoctoral Research Fellow at Karolinska Institutet
Views 1541
Reading time 4 min
published on Dec 20, 2023
Low and Mighty: How Low-Affinity Antibodies Boost Cancer Immunotherapy

Our body is constantly guarded by our immune system, which defends us from external threats like viruses and bacteria, and even internal rogue cells that can become cancerous. Antibodies, which are special proteins in our bodies, play a key role in this defence. They work... click to read more

  • Christian Orr | Beamline Scientist at Diamond Light Source
  • Chelsea Norman | Senior Laboratory Technician at Rosalind Franklin Institute
  • Mark Cragg | Professor at University of Southampton
Views 1662
Reading time 4 min
published on Sep 8, 2023
The needle-free detection of SARS-CoV-2-specific antibodies from urine

While serological tests are not intended to diagnose an acute SARS-CoV-2 (COVID-19) infection, they can indicate the presence of antibodies generated from previous viral exposure or vaccination. Several diagnostic kits to assess the presence of SARS-CoV-2 antibodies are available on the market, all using blood/serum... click to read more

  • Fernanda Fonseca Ramos | Junior Postdoctoral Research Fellow at Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
  • Eduardo Antônio Ferraz Coelho | Full Professor at Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
  • Fernanda Ludolf | Senior Postdoctoral Research Fellow at Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
Views 2231
Reading time 3 min
published on Dec 22, 2022
Mild or severe COVID-19? An antibody story

At this point, we're no strangers to COVID-19, the disease caused by the viral agent SARS-CoV-2. Why some people got very sick with COVID-19, even die, while others had an only mild illness, barely even noticing they are sick, was an enigma even as the... click to read more

  • Arjun Arkal Rao | Data Scientist at ImmunoX initiative, UCSF COMET Consortium, UCSF CoLab University of California San Francisco San Francisco, USA
  • Alexis J. Combes | Group Leader at ImmunoX initiative, UCSF COMET Consortium, UCSF CoLab University of California San Francisco San Francisco, USA
Views 3807
Reading time 3.5 min
published on Aug 30, 2021